WEGOVY
Live / Allowed — Publication / registration review complete (as of 10 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79450360
- Mark type
- Stylized text
- Filed
- 10 Apr 2026
- Published for opposition
- 29 Sept 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases; pharmaceutical preparations for the treatment of neurological disorders, including alcohol dependence and alzheimer's disease; pharmaceutical preparations for the treatment of psychiatric disorders, including depression and anxiety
Owner
- Novo Nordisk A/S, DK
Prosecution history
- 03 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2026 — ASSIGNED TO EXAMINER
- 07 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 07 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 May 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB